Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Vivos Therapeutics (VVOS) Return on Sales (2020 - 2025)

Vivos Therapeutics has reported Return on Sales over the past 6 years, most recently at 0.02% for Q4 2025.

  • Quarterly Return on Sales fell 1.0% to 0.02% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.01% through Dec 2025, changed 0.0% year-over-year, with the annual reading at 0.01% for FY2025, 0.0% changed from the prior year.
  • Return on Sales was 0.02% for Q4 2025 at Vivos Therapeutics, down from 0.01% in the prior quarter.
  • Over five years, Return on Sales peaked at 0.05% in Q4 2022 and troughed at 0.02% in Q4 2025.
  • The 5-year median for Return on Sales is 0.01% (2021), against an average of 0.01%.
  • Year-over-year, Return on Sales rose 5bps in 2021 and then dropped -6bps in 2023.
  • A 5-year view of Return on Sales shows it stood at 0.03% in 2021, then surged by 54bps to 0.05% in 2022, then plummeted by -129bps to 0.01% in 2023, then soared by 42bps to 0.01% in 2024, then plummeted by -138bps to 0.02% in 2025.
  • Per Business Quant, the three most recent readings for VVOS's Return on Sales are 0.02% (Q4 2025), 0.01% (Q3 2025), and 0.01% (Q2 2025).